Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmun... (is European based with apresence in over...)

HOME >> MEDICINE >> TECHNOLOGY

Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases

Date:6/24/2008

is European based with a presence in over 50 countries worldwide and an increasing emphasis on fast growing markets. The company is active in a range of therapeutic areas, focusing on gastroenterology, respiratory, inflammation, pain management, osteoporosis and surgical management. New products are sourced both from its own research and from business partners. Nycomed employs 12,000 people. In 2007, it had annual sales of 3.5 billion euros and an adjusted EBITDA of 1.2 billion euros.

About Micromet, Inc.

Micromet, Inc. (http://www.micromet-inc.com) is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Four of its antibodies are currently in clinical trials, while the remainder of the product pipeline is in preclinical development. The BiTE(R) antibody blinatumomab, also known as MT103 is in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate the T cells of a patient's own immune system, to eliminate cancer cells. Micromet is developing blinatumomab in collaboration with MedImmune, Inc., a subsidiary of AstraZeneca plc. MT110 is the second BiTE antibody in clinical trials, and is being developed by Micromet in a phase 1 clinical trial for the treatment of patients with lung or gastrointestinal cancer. The third clinical stage antibody is adecatumumab, also known as MT201, a human monoclonal antibody which targets epithelial cell adhesion molecule (EpCAM)-expressing solid tumors. Micromet is developing adecatumumab in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. The fourth clinical stage antibod
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)

Post Your Comments:

(Date:12/15/2009)... ST. LOUIS, Dec. 15 KV ... 10, 2009, the Company received a written notice (the ... DTD 7/23/99, a stockholder of the Company, requesting that ... fix a record date for stockholder action by written ... to fill a vacant director seat resulting from Ronald ...

(Date:12/15/2009)... what something looks like up close and personal? ASPEX ... Electron Microscope (PSEM), kicked off its "Send Us Your ... be scanned by one of their PSEMs. ... to 5mm and an imaging resolution of 25nm, capable ... ASPEX will not only scan your sample, but will ...

(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...

Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7 ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2 Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2 New Compound Shrinks Skin Cancers 56070 1 New Compound Shrinks Skin Cancers 56070 2 New Compound Shrinks Skin Cancers 56070 3 New Compound Shrinks Skin Cancers 56070 4 YouTube videos yield clues to brain injury symptom 56068 1 YouTube videos yield clues to brain injury symptom 56068 2 NOAA report explains sea level anomaly this summer along the US Atlantic coast 9772 1

[0] KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent [0] ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign [0] Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans

... Abstract # 2905DENVER, April 20 Scientists ... in Detroit today presented data at the ... Meeting 2009 that represents significant research advancements ... forms of invasive breast cancer.(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ...

... display exceeds performance expectations.LIVONIA, Mich., April 20 On Friday, ... surgeons and their medical support team assembled to perform a ... new LifeVision(TM) family of 3D technologies developed by Absolute Imaging, ... the first time in history that a surgeon ...

Other Medicine Technology:Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference 2 Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference 3 Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 2 Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 3 Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 4

Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses

(Date:12/15/2009)... ,we would have really been in trouble, expert says ... of the pandemic H1N1 swine flu has revealed serious ... health emergencies, a new report says. , The report, ... Robert Wood Johnson Foundation, also finds the dire economy ... "The 2009 H1N1 outbreak is the latest in a ...

(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...

(Date:12/15/2009)... The new compact LifeSpan TR200 folding treadmill, ... ), was highly praised by treadmill review groups ... The compact TR200 folding treadmill received awards for Best ... $1000. ,, The compact LifeSpan TR200 treadmill is ... spaces. "This category buster is a very compact treadmill ...

(Date:12/15/2009)... service, such as tutoring children, can help older ... to a study led by researchers at the ... functional magnetic resonance imaging (fMRI), the researchers found ... made gains in key brain regions that support ... daily life. The study is the first of ...

(Date:12/15/2009)... Affiliate Program, a new employment opportunity for the unemployed or those ... business opportunities in America today. , ... Orlando, FL ... most successful collection agencies, is spreading holiday cheer and good will ... RPS has created an opportunity for out of work Americans ...

Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2 Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3 Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2 Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2 Health News:For older adults, participating in social service activities can improve brain functions 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3

[0] Serious Gaps Revealed in U.S. Response to Health Emergencies [1] Knowledge Networks Expands in Pharma Research With Acquisition of CMR [0] Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill [1] For older adults, participating in social service activities can improve brain functions [0] RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away

... N.Y., Feb. 12 The Lisa Beth,Gerstman Foundation (LBGF) ... of sending physically disabled children in the,Northeast United States ... Foundation send physically disabled children to,summer camp at no ... the New,York Metro area. Foundation camp programs are in ...

... The recent influenza,outbreaks across the country, resulting in ... stark reminder that the influenza virus is a serious ... that influenza hospitalizes more than 20,000 children,younger than 5 ... -- and causes,approximately 100 deaths. These statistics are particularly ...

... soft sounds in response to the sounds that travel ... doctors test newborns hearing. A deaf ear doesnt produce ... of Michigan and Oregon Health and Science University shows ... dont leave the ear the same way they entered. ...

... ... ... FY 2007:, euro 6,961 million ... 15.7% in U.S. dollars(2)), BRIDGEWATER, N.J., Feb. 12 ...

... a Face: Notes on a Life in Medicine, by Maria Siemionow, ... ... you determine the value of a,face? Imagine, for a moment, being unable to ... the burden a disfigured,person carries," writes Dr. Maria Siemionow, section head of plastic,surgery ...

... and the School of Medicine have devised a micro-scale tool - ... complexities of the brain. The system should help scientists better understand ... nervous system. , A report on the work appears as ... journal Lab on a Chip. , The chip weve developed ...

Lisa Beth Gerstman Foundation Awarded CVS/pharmacy Community Grant Childhood Influenza Immunization Coalition Responds to Recent Influenza Outbreaks New findings contradict a prevailing belief about the inner ear Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend Cleveland Clinic Press Releases Book About a Surgeon's Mission to Perform the World's First Full Face Transplant 'Lab on a chip' mimics brain chemistry

... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...

... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...

... with concave seats and large backrests with ... backrests, armrests, and casters and glides. • ... in a variety of environments including: industry, ... care and office. • With reinforced nylon ...

... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...

Medicine Products:

BEP/1Q-PAL-ERB - Polished Aluminum Base - Model 1Q43-PAL-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q66-CAB-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q53-R-CAB-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-CAB-ERB

Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmun...(is European based with apresence in over...),Health